A shocking decision by the Trump administration has sent shockwaves through the medical community, leaving experts concerned about the future of vaccination in the United States. This bold move, which removes a significant portion of childhood vaccines from the recommended schedule, has sparked controversy and raised questions about the country's commitment to disease prevention.
The decision, led by Robert F Kennedy Jr, a known vaccine skeptic and now the secretary of the US Department of Health and Human Services (HHS), has been described as "astounding" by infectious disease specialists. Dr. Jake Scott, a clinical associate professor at Stanford University, emphasizes that this is the largest change in vaccination policy in modern American history.
"It's a decision made without scientific backing or public consultation," says Daniel Jernigan, former director of the National Center for Emerging Zoonotic Infectious Diseases. He goes on to explain that this move will likely worsen vaccine accessibility and increase the risk of disease outbreaks.
Health officials, under Kennedy's leadership, seem to be advocating for fewer vaccines, according to Jernigan. They are allegedly exaggerating risks and downplaying the benefits, causing confusion among parents and healthcare providers.
Some vaccines, such as those for hepatitis A, RSV, hepatitis B, and meningitis, are now only recommended for high-risk groups. Others, like influenza, rotavirus, and meningococcal disease vaccines, are now offered only under shared clinical decision-making, a rare designation that typically requires a doctor's recommendation. Even the COVID-19 vaccine has been limited in this way. Additionally, the CDC will now recommend only one dose of the HPV vaccine instead of the previously recommended two doses.
Health officials claim that this new schedule will bring the US in line with "peer, developed countries," as instructed by Donald Trump. However, a closer look reveals that most other high-income countries have similar vaccine schedules to the US's previous recommendations.
Countries like the UK, Canada, Australia, Japan, and many European nations universally recommend vaccines for influenza, rotavirus, and hepatitis B. All but Japan also routinely recommend vaccines against meningococcal disease. Additionally, several of these countries recommend vaccines that the US does not, such as the rotavirus vaccine in Japan and the chickenpox vaccine in the UK.
"Many of these countries are moving towards offering more protection through vaccines," explains Dr. Scott. "A lot of countries are expanding their vaccine schedules, and many have looked to the US for guidance in the past."
The new US schedule now resembles that of Denmark, a much smaller nation with universal healthcare. "Denmark is an outlier when it comes to vaccine recommendations," Scott adds. "They have the most minimalist childhood vaccine schedule among high-income nations."
The US itself is an outlier in terms of its healthcare system and social safety nets. It is the only high-income country without universal healthcare and paid family leave.
"We need to follow the lead of our peer countries and implement universal healthcare," Jernigan emphasizes.
The US's unique position as a large, diverse nation with a fragmented healthcare system and significant health disparities makes it vulnerable to disease outbreaks. Nearly a third of the population lacks access to primary care, and the lack of healthcare access or paid sick leave can lead to diseases spreading more rapidly before individuals seek medical attention.
"In the US, disease moves differently," Scott explains. "With dense urban centers, rural areas with limited healthcare access, and frequent travel across state and international borders, young people can be exposed to new disease threats, such as meningitis, when they move from small towns to large cities or attend major universities."
In nations with more comprehensive healthcare systems, it may be easier for high-risk populations to access vaccines that are not universally recommended. For example, children born to pregnant people with hepatitis B are at high risk of severe illness, yet in the US, they are the least likely to receive the hepatitis B vaccine due to limited access to medical testing and follow-up care.
An HHS spokesperson, Andrew Nixon, attributed the change to declining trust in public health but provided no evidence to support this claim.
Even countries with universal healthcare recommend similar vaccines to those once recommended by the US.
"I've never seen anything like this, where what other countries do is given the same weight as scientific evidence," Jernigan says. "It's like recommending that all drivers in the US switch to driving on the left side of the road because other countries do so."
Scott agrees, saying that the recommendations seem to be more about justifying a predetermined conclusion rather than aligning with peer nations.
What's even more concerning, according to Jernigan, is that the decision was made without following established scientific processes. There was no public comment, no discussion with the Advisory Committee on Immunization Practices (ACIP), and no feedback from external scientists or professional groups like the American Academy of Pediatrics (AAP).
"We have a sweeping health policy that lacks public engagement," Jernigan says. "The process for making transparent decisions on vaccines has been in place for a long time, but this administration refuses to use it."
The administration instead released a 33-page report authored by Tracy Beth Høeg, a frequent vaccine skeptic now in charge of drug regulation at the FDA, and Martin Kulldorff, a biostatistician who briefly served as an ACIP adviser before being appointed to the HHS.
"It's very odd to have a document that leads to such significant policy change list only two authors," Jernigan points out. "It ends up being more like an opinion piece than a scientific report."
The announcement itself lacked transparency, with a small group of journalists selected by HHS to be briefed about the changes, excluding The Guardian.
Even the president's directive to re-examine the vaccine schedule was unusual, Jernigan notes. "I can't think of another instance where a president has said, 'Let's change the cholesterol-lowering drug Atvorstatin.'"
Officials claim that they constantly monitor vaccines for safety signals, but no new evidence of potential harms has been made public.
"The science hasn't changed; it's the decision-makers and their conclusions that have," Scott says.
Jernigan warns that such unscientific changes will have significant negative consequences. "We cannot let this become the new normal for government actions. The government is essentially saying, 'Stop listening to us from now on.' It's truly unfortunate."
He hopes that patients will continue to seek out vaccines and that healthcare providers will continue to recommend them. "You don't want to be the parent of a child who attends a college with a meningitis outbreak and ends up losing a limb or dying because they weren't vaccinated."
This controversial decision has left many questioning the future of vaccination in the US and the potential impact on public health.
